D.J. St. Germain’s GSK GSK Stock Holding History

D.J. St. Germain’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$69.7K	Buy	1,329 +265	+25%	+$14K	﹤0.01%	425
2026 Q1	$58.7K	Hold	1,064	–	–	﹤0.01%	432
2025 Q4	$52.2K	Sell	1,064 -80	-7%	-$3.73K	﹤0.01%	471
2025 Q3	$49.4K	Sell	1,144 -560	-33%	-$21.9K	﹤0.01%	471
2025 Q2	$65.4K	Buy	1,704 +1,180	+225%	+$45.1K	﹤0.01%	433
2025 Q1	$20.3K	Sell	524 -265	-34%	-$9.7K	﹤0.01%	504
2024 Q4	$26.7K	Buy	789 +522	+196%	+$18.8K	﹤0.01%	490
2024 Q3	$10.9K	Hold	267	–	–	﹤0.01%	533
2024 Q2	$10.3K	Hold	267	–	–	﹤0.01%	533
2024 Q1	$11.4K	Sell	267 -40	-13%	-$1.65K	﹤0.01%	548
2023 Q4	$11.4K	Sell	307 -80	-21%	-$2.87K	﹤0.01%	544
2023 Q3	$14K	Hold	387	–	–	﹤0.01%	499
2023 Q2	$13.8K	Buy	+387	New	+$13.9K	﹤0.01%	508
2022 Q4	$2.81K	Buy	+80	New	+$2.67K	﹤0.01%	333

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

D.J. St. Germain's GSK Position: Q2 2026 in Review

D.J. St. Germain increased its GSK (GSK) stake by 25% in Q2 2026, buying an estimated $14K and bringing the position to 1,329 shares worth $69.7K. The position accounts for ﹤0.01% of the portfolio, ranked #425.

D.J. St. Germain first reported a position in GSK in Q4 2022 and has held it in 14 quarters since. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

D.J. St. Germain held 1,329 shares of GSK worth $69.7K as of Q2 2026.
D.J. St. Germain bought 265 GSK shares in Q2 2026, an estimated $14K.
GSK made up ﹤0.01% of D.J. St. Germain's portfolio in Q2 2026, its #425 holding.
D.J. St. Germain first reported a position in GSK in Q4 2022 and has held it in 14 quarters since.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on D.J. St. Germain's 13F filing for Q2 2026, filed 21 Jul 2026.